Has Jessica Wilson, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,696 in general payments to Jessica Wilson, MD across 146 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jessica Wilson, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jessica Wilson, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jessica Wilson, MD

Dermatology · Covington, LANPI 1699270520

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.3% of the total across 146 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AbbVie at 26.7% of the total. Reporting peaked in 2024 at $1,359 and has fallen 80.8% since, to $260 in 2025. That places this record below the midpoint for dermatology clinicians in LA, where the typical reported total is $5,293.

$2,696in general payments, 2019–2025

Across 146 payments — averaging $18.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$719
Merz North America, Inc.$241
E.r. Squibb & Sons, L.L.C.$230
Johnson & Johnson$227
Pfizer$227
Regeneron Healthcare Solutions, Inc.$153
plus $898 from 16 others

What the payments were for

Food & beverage$2,51593%
Education$1817%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	58	$719
Merz North America, Inc.	4	$241
E.r. Squibb & Sons, L.L.C.	17	$230
Johnson & Johnson(2 entities)	9	$227
Pfizer	9	$227
Regeneron Healthcare Solutions, Inc.	5	$153
Lilly USA, LLC	7	$144
Sun Pharmaceutical Industries Inc.	7	$119
LEO Pharma Inc.	5	$91
Incyte Corporation	4	$89
Amgen	4	$89
UCB, Inc.	3	$64
GSK	3	$61
Sanofi	2	$48
Arcutis Biotherapeutics, Inc.	2	$36
Almirall LLC	1	$34
Hill Dermaceuticals, Inc.	1	$27
Mayne Pharma Commercial LLC	1	$23
Dermavant Sciences, Inc.	1	$20
Paratek Pharmaceuticals, Inc.	1	$19
Galderma Laboratories, L.p.	1	$17
Journey Medical Corporation	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

XEOMIN$111

How this compares

$2,696 in reported general payments places this provider in the 35th percentile of 189 dermatology providers in Louisiana.

See all dermatology providers in Louisiana →

Medicare billing

Part B allowed, 2024

$127,454

Medicare patients

291

Services billed

1,656

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Skyrizi PenRisankizumab-Rzaa	12	$258,595
Dupixent PenDupilumab	21	$76,782
Ketoconazole	155	$2,673
Clobetasol Propionate	59	$2,200
Metronidazole	31	$1,640
Triamcinolone Acetonide	155	$1,500
Fluorouracil	15	$1,073
Ammonium Lactate	36	$1,013
Doxycycline Hyclate	55	$832
Clindamycin Phosphate	21	$603
Ciclopirox	19	$510
Doxycycline Monohydrate	11	$358
Mupirocin	36	$297
Finasteride	33	$236
Hydroxyzine Hcl	19	$230

Paid to pharmacies, not to this prescriber.

Other dermatology in Covington

Christel MalinskiCovington$80K
Emily GrieshaberCovington$10K
Kristen BiceCovington$9K
Katherine HolcombMetairie$411K
William ClaiborneNew Orleans$374K
Blair BuddenLafayette$329K
Erin BohNew Orleans$277K
Mara HaseltineNew Orleans$276K
Sarah HaydelHouma$265K
Frankie RholdonLafayette$227K

See the full list for Louisiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →